1.0Avalere Health Advisoryhttps://advisory.avalerehealth.comManufacturer Considerations for Rare-Disease Drug Development | Avalere Health Advisoryrich600338<blockquote class="wp-embedded-content" data-secret="bnaW40XRoq"><a href="https://advisory.avalerehealth.com/insights/manufacturer-considerations-for-rare-disease-drug-development">Manufacturer Considerations for Rare-Disease Drug Development</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://advisory.avalerehealth.com/insights/manufacturer-considerations-for-rare-disease-drug-development/embed#?secret=bnaW40XRoq" width="600" height="338" title="“Manufacturer Considerations for Rare-Disease Drug Development” — Avalere Health Advisory" data-secret="bnaW40XRoq" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
https://advisory.avalerehealth.com/wp-content/uploads/2022/01/24922-1-Shelby_Harrington-400x600-1.jpg600400[vc_row][vc_column][vc_column_text]Drug manufacturers bringing therapies to market for rare diseases face challenges typically unseen with therapies for more prevalent conditions. These challenges span multiple stages—from clinical development through commercialization—and require coordinated efforts from medical affairs, health economics and outcomes research, policy, advocacy, and market access functions to execute successful evidence planning, stakeholder engagement, and patient access…